- Home
- XPON vs OGEN Comparison
XPON vs OGEN Comparison
Compare XPON & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- OGEN
- Stock Information
- Founded
- XPON 2016
- OGEN 1996
- Country
- XPON United States
- OGEN United States
- Employees
- XPON N/A
- OGEN N/A
- Industry
- XPON Electronic Components
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- XPON Technology
- OGEN Health Care
- Exchange
- XPON Nasdaq
- OGEN Nasdaq
- Market Cap
- XPON 3.2M
- OGEN 2.5M
- IPO Year
- XPON 2022
- OGEN N/A
- Fundamental
- Price
- XPON $0.90
- OGEN $1.39
- Analyst Decision
- XPON
- OGEN
- Analyst Count
- XPON 0
- OGEN 0
- Target Price
- XPON N/A
- OGEN N/A
- AVG Volume (30 Days)
- XPON 43.4K
- OGEN 1.2M
- Earning Date
- XPON 08-13-2025
- OGEN 08-08-2025
- Dividend Yield
- XPON N/A
- OGEN N/A
- EPS Growth
- XPON N/A
- OGEN N/A
- EPS
- XPON N/A
- OGEN N/A
- Revenue
- XPON $6,702,411.00
- OGEN N/A
- Revenue This Year
- XPON $61.26
- OGEN N/A
- Revenue Next Year
- XPON N/A
- OGEN N/A
- P/E Ratio
- XPON N/A
- OGEN N/A
- Revenue Growth
- XPON 23.07
- OGEN N/A
- 52 Week Low
- XPON $0.60
- OGEN $1.32
- 52 Week High
- XPON $120.00
- OGEN $75.60
- Technical
- Relative Strength Index (RSI)
- XPON 50.32
- OGEN 26.99
- Support Level
- XPON $0.88
- OGEN $1.40
- Resistance Level
- XPON $0.96
- OGEN $1.58
- Average True Range (ATR)
- XPON 0.08
- OGEN 0.28
- MACD
- XPON -0.00
- OGEN -0.13
- Stochastic Oscillator
- XPON 66.61
- OGEN 2.44
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.